Background illustration for clinical trials search

Paid Clinical Trials Iowa

Discover 657 paid clinical trials in Iowa. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Quantitative MRI Assessment of Breast Cancer Therapy Response

for
Breast Cancer
Location: Royal Oak MI, Iowa City IA, Seattle WA
Sponsor: Corewell Health East

Sex: All

Age: 18+

Code: NCT05704062

Recruiting

Limited-duration Teclistamab

for
Myeloma Multiple
Location: New York NY, Philadelphia PA, Iowa City IA,
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT05932680

Phase2, Recruiting

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

for
Advanced Melanoma
Location: Providence RI, Lebanon NH, Lake Success NY,
Sponsor: Replimune, Inc.

Sex: All

Age: 12+

Code: NCT06264180

Phase3, Recruiting

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

for
Amblyopia
Location: Boston MA, New York NY, Philadelphia PA, Norfolk VA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 8 - 12

Code: NCT06524882

Phase3, Recruiting

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

for
Radiation Retinopathy, Visual Impairment
Location: Boston MA, Manchester CT, Philadelphia PA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18+

Code: NCT05844982

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: Boston MA, Shirley NY, New Haven CT, Lebanon NH,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase2, Recruiting

Post-Filter Hematocrit

for
Continuous Renal Replacement Therapy, Renal Failure,
Location: Iowa City IA
Sponsor: Gwyndolyn M. Radford

Sex: All

Age: 18+

Code: NCT07293936

Recruiting

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

for
Intracranial Meningioma
Location: Boston MA, New Haven CT, New York NY, Durham NC,
Sponsor: RTOG Foundation, Inc.

Sex: All

Age: 18+

Code: NCT06955169

Phase2, Recruiting

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

for
Angioimmunoblastic T-cell Lymphoma,
Location: Boston MA, Saint Johnsbury VT, Lebanon NH, Commack NY,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT04803201

Phase2, Recruiting

The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy

for
Gestational Diabetes Mellitus (GDM), Postpartum Women,
Location: Iowa City IA
Sponsor: Anna Stanhewicz, PhD

Sex: Female

Age: 18 - 50

Code: NCT06911372

Phase1, Recruiting

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

for
Malignant Digestive System Neoplasm,
Location: Portland ME, Scarborough ME, Newark DE, Elkton MD,
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT07215624

Recruiting

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

for
Alopecia Areata
Location: Iowa City IA, Minneapolis MN, Webster TX, Houston TX,
Sponsor: Pfizer

Sex: All

Age: 12+

Code: NCT06873945

Phase3, Recruiting

An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury

for
Mild Traumatic Brain Injury, Concussion,
Location: Waukee IA
Sponsor: Rebiscan, Inc.

Sex: All

Age: 12+

Code: NCT07742878

Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma,
Location: Augusta ME, Scarborough ME, Providence RI, Westerly RI,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05256225

Phase3, Recruiting

Quality of End-of-Life Care for Children With Cancer

for
Childhood Hematopoietic and Lymphatic System Neoplasm,
Location: Providence RI, The Bronx NY, Albany NY, Wilmington DE,
Sponsor: Children's Oncology Group

Sex: All

Age: 18+

Code: NCT07412002

Recruiting

Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

for
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Location: Philadelphia PA, Charlottesville VA, Charleston SC,
Sponsor: Airiver Medical, Inc.

Sex: All

Age: 18+

Code: NCT07290140

Recruiting

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Migraine
Location: Boston MA, Waltham MA, Waterbury CT, Commack NY,
Sponsor: Kallyope Inc.

Sex: All

Age: 18 - 70+

Code: NCT07645924

Phase3, Recruiting

Amygdala Insula Retraining in the Management of Perimenopause Symptoms

for
Perimenopause, Menopausal Complaints
Location: Decorah IA
Sponsor: Chronic Conditions Research Fund

Sex: Female

Age: 38 - 60

Code: NCT07427459

Recruiting

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

for
Advanced Clear Cell Renal Cell Carcinoma,
Location: Peabody MA, Burlington MA, Livonia MI, Canton MI,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07383441

Phase3, Recruiting

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

for
Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma,
Location: Nashville TN, Iowa City IA, Dallas TX, Fullerton CA,
Sponsor: TORL Biotherapeutics, LLC

Sex: All

Age: 18+

Code: NCT07439653

Phase1, Phase2, Recruiting

Popular cities in Iowa

Offering a distinguished healthcare infrastructure and top class research institutions, Iowa has emerged as a significant base for a wide range of clinical trials. Major institutions such as the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center are at the forefront of these studies, driving advancements in fields like oncology, cardiovascular research, and more. Iowa’s commitment to medical innovation and its growing network of research centers make it a developing hub in cutting-edge clinical trials.

Why choose Iowa for clinical trials?

Iowa offers distinct advantages for those participating in clinical trials. The state's distinct population, combined with its strong agricultural and rural communities, provides a diverse range of participants that enhances the accuracy and applicability of research findings. Iowa is also recognized for its innovative research environment and its cutting-edge medical advancements, driven by leading institutions such as the University of Iowa.

By choosing to participate in a clinical trial in Iowa, participants contribute to critical medical research while benefiting from a well-established and supportive clinical research infrastructure that promotes breakthroughs in patient care and treatment.

Common conditions studied in Iowa

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Iowa